Phase I clinical trials (CT) forge on despite COVID-19

Bardaji, M. J. Lostes, Aliende, E.; Moreno, M.; Oberoi, H. K.; Braña, I.; Saavedra, O.; Villar, M. Vieito, Alonso, G.; Galvao, V.; Carballo, N.; Beltran, M.; Rovira, P.; Cidoncha, I.; Manich, C. Saura, Mercade, T. Macarulla, Oaknin, A.; Galceran, J. Carles, Felip, E.; Garralda, E.; Pujol, S. Perez

Bardaji, M. J. Lostes, Aliende, E.; Moreno, M.; Oberoi, H. K.; Braña, I.; Saavedra, O.; Villar, M. Vieito, Alonso, G.; Galvao, V.; Carballo, N.; Beltran, M.; Rovira, P.; Cidoncha, I.; Manich, C. Saura, Mercade, T. Macarulla, Oaknin, A.; Galceran, J. Carles, Felip, E.; Garralda, E.; Pujol, S. Perez.

Annals of Oncology ; 32:S1153-S1154, 2021.

Article in English | Academic Search Complete | ID: covidwho-1442241

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: Academic Search Complete Type of study: Prognostic study Language: English Journal: Annals of Oncology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google